生活质量对胃肠道症状与未来就医行为关联的调节作用有限
该研究基于瑞典人群的12年前瞻性数据,纳入1159名受试者(57%女性,平均年龄48.6岁),其中164人符合Rome II的IBS标准,分析SF-36生活质量域对胃肠道症状与未来就医利用关系的调节作用。结果显示胃肠道症状与未来就医利用相关,但多数模型未达统计学显著性,不支持特定生活质量域的调节作用,且IBS状态不影响该调节假设。
要点
- 胃肠道症状可预测未来就医利用,但特定生活质量域未显示调节作用。
- 多数调节模型未达统计学显著性,IBS状态不影响调节假设。
- 未来需继续探索其他心理、社会和症状变量以识别高就医者。
核心结论
- 特定生活质量域未影响胃肠道症状与未来就医寻求之间的关系。
研究设计与样本
- 瑞典人群为基础的前瞻性研究,分析12年期间医疗使用情况。
- 基线时用胃肠症状评定量表测胃肠道症状,SF-36测生活质量。
- 1159名受试者(57%女性,平均年龄48.6岁)的健康记录与初始调查匹配,其中164人按Rome II标准归类为IBS。
- 采用负二项或逻辑模型评估特定生活质量域对胃肠道症状与未来就医利用关系的调节效应。
主要发现
- 胃肠道症状与未来就医利用相关。
- 特定生活质量域对该关系的调节作用未获支持,多数模型未达统计学显著性。
- IBS状态未改变调节假设。
临床怎么用
- 临床识别高就医者时,不应仅依赖生活质量域来预测胃肠道症状相关的就医行为。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: An individual's drive to seek medical help remains a complex behavioural process, incorporating psychological, social and symptom-specific factors. Within irritable bowel syndrome (IBS), gastrointestinal symptoms only predict a small portion of the high healthcare-seeking experienced. AIM: To examine the moderating role of quality of life (QoL) domains on this relationship to help explain the variance observed. METHODS: This is an analysis of a Swedish population-based prospective study of healthcare use over a 12-year period. At baseline, gastrointestinal symptoms were measured with the valid Gastrointestinal Symptom Rating Scale, and QoL via the SF-36. 1159 subjects (57% female; mean age 48.6 years) had their health records matched with the initial survey. 164 were classified as IBS by Rome II criteria. Negative binomial or logistic models were fit to evaluate the moderating effect of particular QoL domains on the relationship between gastrointestinal symptoms and prospective healthcare utilisation. RESULTS: Gastrointestinal symptoms were associated with prospective healthcare use, but moderation in this relationship by particular QoL domains was not supported; most models did not reach statistical significance. Furthermore, the impact of IBS status did not alter the moderation hypotheses. CONCLUSIONS: Particular QoL domains did not impact the relationship between gastrointestinal symptoms on prospective healthcare seeking. Future research should continue to examine other psychological, social and symptom variables to identify predictors of high healthcare consumers in IBS.
引用
- McNaughton DT, Andreasson A, Ljótsson B, et al. Limited evidence of moderation of the association between gastrointestinal symptoms and prospective healthcare utilisation by quality of life. Aliment Pharmacol Ther. 2021. PMID: 34664298. doi:10.1111/apt.16651
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。